Oncogene - Table of Contents alert Volume 31 Issue 13

TABLE OF CONTENTS Volume 31, Issue 13 (March 2012) In this issue Review Original Articles Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Cancer Immunology Special Issue and Web Focus The January special issue of Cellular & Molecular Immunology and accompanying web focus on Cancer Immunology present important strategies for generating potent and lasting anti-tumor immunity. Access the Cancer Immunology Special Issue and Web Focus today!   Review Top DNA methylation-associated silencing of tumor-suppressor microRNAs in cancer P Lopez-Serra and M Esteller Oncogene 2012 31: 1609-1622; advance online publication, August 22, 2011; 10.1038/onc.2011.354 Abstract | Full Text Original Articles Top MicroRNA-mediated upregulation of integrin-linked kinase promotes Src-induced tumor progression C Oneyama, E Morii, D Okuzaki, Y Takahashi, J Ikeda, N Wakabayashi, H Akamatsu, M Tsujimoto, T Nishida, K Aozasa and M Okada Oncogene 2012 31: 1623-1635; advance online publication, August 22, 2011; 10.1038/onc.2011.367 Abstract | Full Text A role for caveolin-1 in desmoglein binding and desmosome dynamics D Brennan, S Peltonen, A Dowling, W Medhat, K J Green, J K Wahl, III, F Del Galdo and M G Mahoney Oncogene 2012 31: 1636-1648; advance online publication, August 15, 2011; 10.1038/onc.2011.346 Abstract | Full Text Erythropoietin receptor contributes to melanoma cell survival in vivo S M Kumar, G Zhang, B C Bastian, M O Arcasoy, P Karande, A Pushparajan, G Acs and X Xu Oncogene 2012 31: 1649-1660; advance online publication, August 22, 2011; 10.1038/onc.2011.366 Abstract | Full Text Efficacy of CHK inhibitors as single agents in MYC-driven lymphoma cells P T Ferrao, E P Bukczynska, R W Johnstone and G A McArthur Oncogene 2012 31: 1661-1672; advance online publication, August 15, 2011; 10.1038/onc.2011.358 Abstract | Full Text CAPC negatively regulates NF-κB activation and suppresses tumor growth and metastasis X-F Liu, L Xiang, Y Zhang, K G Becker, T K Bera and I Pastan Oncogene 2012 31: 1673-1682; advance online publication, August 8, 2011; 10.1038/onc.2011.355 Abstract | Full Text Acceleration of clear cell renal cell carcinoma growth in mice following bevacizumab/Avastin treatment: the role of CXCL cytokines R Grepin, M Guyot, M Jacquin, J Durivault, E Chamorey, A Sudaka, C Serdjebi, B Lacarelle, J-Y Scoazec, S Negrier, H Simonnet and G Pages Oncogene 2012 31: 1683-1694; advance online publication, September 12, 2011; 10.1038/onc.2011.360 Abstract | Full Text Genome-wide mapping of Myc binding and gene regulation in serum-stimulated fibroblasts D Perna, G Fagà, A Verrecchia, M M Gorski, I Barozzi, V Narang, J Khng, K C Lim, W-K Sung, R Sanges, E Stupka, T Oskarsson, A Trumpp, C-L Wei, H Müller and B Amati Oncogene 2012 31: 1695-1709; advance online publication, August 22, 2011; 10.1038/onc.2011.359 Abstract | Full Text Insulin-like growth factor-binding protein-1 (IGFBP-1) regulates human schwannoma proliferation, adhesion and survival S Ammoun, M C Schmid, L Zhou, N Ristic, E Ercolano, D A Hilton, C M Perks and C O Hanemann Oncogene 2012 31: 1710-1722; advance online publication, September 5, 2011; 10.1038/onc.2011.357 Abstract | Full Text Pancreatic β-cells activate a JunB/ATF3-dependent survival pathway during inflammation E N Gurzov, J Barthson, I Marhfour, F Ortis, N Naamane, M Igoillo-Esteve, C Gysemans, C Mathieu, S Kitajima, P Marchetti, T F Ørntoft, L Bakiri, E F Wagner and D L Eizirik Oncogene 2012 31: 1723-1732; advance online publication, August 15, 2011; 10.1038/onc.2011.353 Abstract | Full Text Targeting activation-induced cytidine deaminase prevents colon cancer development despite persistent colonic inflammation A Takai, H Marusawa, Y Minaki, T Watanabe, H Nakase, K Kinoshita, G Tsujimoto and T Chiba Oncogene 2012 31: 1733-1742; advance online publication, August 15, 2011; 10.1038/onc.2011.352 Abstract | Full Text Advertisement Call for papers! Submit your best work in cancer research, including mechanisms of cellular oncogene activation, structure and function of encoded proteins, DNA and RNA tumor viruses and all other aspects of oncogene structure and function. Our online submission process is easy and can assist you in becoming part of this distinguished journal. Visit our Author page to learn about the benefits of publishing in the Journal and for guidelines on how to submit your paper.   Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.